Fuck off Maris

do you get all your information from this board? Go fuck yourself.

 

The fuck you so angry? Lost money longing this this stock? He tells the truth about this radioactive waste!

 

He says it like it is, son!


Wells Fargo analyst David Maris weighed in on Valeant Pharmaceuticals (NYSE: VRX) after-hours Wednesday, asking 'did 50+ salespeople just leave.

Maris commented, "We recently asked Valeant whether industry speculation is correct that approximately 50 or more of Valeant’s gastrointestinal (GI) salespeople recently left Valeant en masse to join Synergy Pharmaceuticals (NASAQ: SGYP) following the FDA's approval of Synergy’s plecanatide on January 19, 2017. Valeant indicated that a number of salespeople have left but would not confirm how many. Valeant went further to explain that it is not uncommon for salespeople to accept offers from another drug company contingent on approval of a drug, and when the drug is approved, they leave. We reached out to Synergy Pharmaceuticals which would only comment that it has been very successful in hiring a large number of experienced salespeople, many with 10+ years in GI sales. We think if Valeant did lose approximately 50+ salespeople it may be another setback to the Salix/GI salesforce and one that Valeant cannot afford given recent prescription trends on Xifaxan and the overall GI franchise, which have shown weakness."

Underperform price target of $11.50

For an analyst ratings summary and ratings history on Valeant Pharmaceuticals click here. For more ratings news on Valeant Pharmaceuticals click here.

Shares of Valeant Pharmaceuticals closed at $16.40 yesterday.

 

David Maris is the Scum of the Earth. He has a vendetta against Valeant when he was fired for fraud by Bank of America when Biovil (now part of Valeant) exposed him. Sales people always come and go and Valeant has been adding 100 new GI reps so IF 50 left they are still plus 50 with 50 more to hire.

A lot of sales people are losers that come on here and whine about a manager does this or that or a company does this or that. Wa wa wa. No one Cares! Sales people are a dime a dozen in most cases!

 

No he does not! He was wrong when he had a price target in the 60's less than a year ago!


Wells Fargo analyst David Maris weighed in on Valeant Pharmaceuticals (NYSE: VRX) after-hours Wednesday, asking 'did 50+ salespeople just leave.

Maris commented, "We recently asked Valeant whether industry speculation is correct that approximately 50 or more of Valeant’s gastrointestinal (GI) salespeople recently left Valeant en masse to join Synergy Pharmaceuticals (NASAQ: SGYP) following the FDA's approval of Synergy’s plecanatide on January 19, 2017. Valeant indicated that a number of salespeople have left but would not confirm how many. Valeant went further to explain that it is not uncommon for salespeople to accept offers from another drug company contingent on approval of a drug, and when the drug is approved, they leave. We reached out to Synergy Pharmaceuticals which would only comment that it has been very successful in hiring a large number of experienced salespeople, many with 10+ years in GI sales. We think if Valeant did lose approximately 50+ salespeople it may be another setback to the Salix/GI salesforce and one that Valeant cannot afford given recent prescription trends on Xifaxan and the overall GI franchise, which have shown weakness."

Underperform price target of $11.50

For an analyst ratings summary and ratings history on Valeant Pharmaceuticals click here. For more ratings news on Valeant Pharmaceuticals click here.

Shares of Valeant Pharmaceuticals closed at $16.40 yesterday.[/QUOTE]

 

No he does not! He was wrong when he had a price target in the 60's less than a year ago!


Wells Fargo analyst David Maris weighed in on Valeant Pharmaceuticals (NYSE: VRX) after-hours Wednesday, asking 'did 50+ salespeople just leave.

Maris commented, "We recently asked Valeant whether industry speculation is correct that approximately 50 or more of Valeant’s gastrointestinal (GI) salespeople recently left Valeant en masse to join Synergy Pharmaceuticals (NASAQ: SGYP) following the FDA's approval of Synergy’s plecanatide on January 19, 2017. Valeant indicated that a number of salespeople have left but would not confirm how many. Valeant went further to explain that it is not uncommon for salespeople to accept offers from another drug company contingent on approval of a drug, and when the drug is approved, they leave. We reached out to Synergy Pharmaceuticals which would only comment that it has been very successful in hiring a large number of experienced salespeople, many with 10+ years in GI sales. We think if Valeant did lose approximately 50+ salespeople it may be another setback to the Salix/GI salesforce and one that Valeant cannot afford given recent prescription trends on Xifaxan and the overall GI franchise, which have shown weakness."

Underperform price target of $11.50

For an analyst ratings summary and ratings history on Valeant Pharmaceuticals click here. For more ratings news on Valeant Pharmaceuticals click here.

Shares of Valeant Pharmaceuticals closed at $16.40 yesterday.[/QUOTE]

 

David Maris is the Scum of the Earth. He has a vendetta against Valeant when he was fired for fraud by Bank of America when Biovil (now part of Valeant) exposed him. Sales people always come and go and Valeant has been adding 100 new GI reps so IF 50 left they are still plus 50 with 50 more to hire.

A lot of sales people are losers that come on here and whine about a manager does this or that or a company does this or that. Wa wa wa. No one Cares! Sales people are a dime a dozen in most cases!

 

I was on periscope watching my manager fire a guy YIKES !

 

Conceptually, I hate sales reps...

I get that everyone has a job to due, but there's something unethical if you can go from telling doctors how "This is THE drug your patient needs to get better" to "No wait, it's THIS drug" simply because you changed companies...

Either the drug is better or it isn't. Like I said, I get that you need to put food on a table, but to be able to do that kind of a 180 and sleep at night is beyond me.

When I'm sick, I want my doctor to prescribe the best drug for my situation, not the inferior drug with a fancy sales rep who takes him out to dinner. I'm not saying this is valeant or any other company because they're all guilty of this.

Hence, I hate sales reps on principle. Because you'll never get the truth, just the pitch.

Still, you do what you do to get by. Don't fault you guys for that. I just know I couldn't do it.

 

Unfortunately - your numbers are wrong and he is right.

 

I am from glad there are people like Maris out there exposing VRX.

 

Maris is a hack. He scours message boards for information he puts in his stupid reports.

Next time, mention that you heard about the "industry speculation" on Cafe Pharma ya fucking shithead!

 

Like Left, Maris performed his own brand of research on the company. Weather it was true or not, the effect was the same. Ackman did it as well, when it rode from 50 to 250.

Why target Maris, if you're losing money?

 

Maris' "proprietary research" is literally hanging out on on this board and recycling whatever rumors we make up, and this is a good example of him using a "research note" to basically shovel shit from this board.

"Oh, it's just the reps talking about their daily lives" is total bullshit. We make up rumors. We pretend to be reps. Longs and shorts do this. It comes with the territory of having an anonymous internet board.

 

If everybody knows this, why do you care? He was already fired by bank of america for publishing fake news, so when wells fargo figures out that he's making it up, then they will fire him too.

 

Maris < internet board members

 

Bank of America fired Maris because his negative (yet true!) reports were screwing up their juicy percentages for bond issues, financial advice, etc with the company. It was a financial decision, not on the merit of the information. Years later, BoA paid a settlement to Maris for the circumstances of their false and damaging dismissal.

Maris was right, and is a hero as is Roddy Boyd of SIRF for exposing this fraudulent company, Valeant, as led by former CEO J.Michael Pearson.

 

Roddy Boyd of SIRF, publicity whore that he is, has had his hat in his hand lately, trying to get money. I guess being the self-described genius that he says he is doesn't pay to keep the lights on.

Maybe he needs a real job, like the rest of us poor slobs.

A total douche canoe.

 

You must have lost a bundle of bucks on $VRX. Guess that means you don't have any left to donate to the non-profit Southern Investigative Research Foundation.

Boyd's reporting on illegal behavior at Insys Pharmaceuticals just resulted in the conviction of two doctors this week. I'd say he is pretty successful at what he does.

 

Nice try, David Maris.